ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| CEREBAIN BIOTECH CORP. Delisted | — | United States of America | — | 147 |
| TISSERA INC Delisted | — | United States of America | — | 147 |
| TYK Medicines, Inc | 2410 | Hong Kong | — | 147 |
| Cytophage Technologies Ltd. | CYTO | Canada | — | 146 |
| VERDE SCIENCE, INC. Delisted | — | United States of America | — | 146 |
| ROKIT HEALTHCARE Inc. | 376900 | South Korea | — | 145 |
| Beijing Luzhu Biotechnology Co., Ltd. | 2480 | Hong Kong | — | 144 |
| Future Medicine Co., Ltd. | 341170 | South Korea | — | 142 |
| Ayala Pharmaceuticals Inc Delisted | AYLA | United States of America | — | 141 |
| MOLECULAR BIOSYSTEMS INC Delisted | — | United States of America | — | 141 |
| Neural Therapeutics Inc. | NURL | Canada | — | 141 |
| TAIWAN BIO THERAPEUTICS INC. | 6892 | Taiwan | — | 140 |
| Abera Bioscience AB | ABERA | Sweden | — | 139 |
| Nightstar Therapeutics PLC Delisted | NITE_old | United States of America | — | 139 |
| Orum Therapeutics, Inc. | 475830 | South Korea | — | 139 |
| PEPLIN INC Delisted | — | United States of America | — | 139 |
| CELLCYTE GENETICS CORP Delisted | — | United States of America | — | 138 |
| Synthorx Inc Delisted | THOR | United States of America | — | 138 |
| ENTEST GROUP, INC. Delisted | — | United States of America | — | 137 |
| Phoenix Life Sciences International Limited. Delisted | — | United States of America | — | 137 |
| PROTEONOMIX, INC. Delisted | — | United States of America | — | 137 |
| Transition Therapeutics Inc. Delisted | TTH | Canada | — | 137 |
| CinCor Pharma Inc Delisted | CINC | United States of America | — | 136 |
| Andros Pharmaceuticals Co.,Ltd | 6917 | Taiwan | — | 135 |
| Freeline Therapeutics Holdings Plc Delisted | FRLN | United States of America | — | 135 |
| CytRx Oncology Corp Delisted | — | United States of America | — | 133 |
| Evommune, Inc. | EVMN | United States of America | — | 133 |
| Prevail Therapeutics Inc Delisted | PRVL | United States of America | — | 132 |
| Pandion Therapeutics Inc Delisted | PAND | United States of America | — | 129 |
| Hanx Biopharmaceuticals (Wuhan) Co., Ltd. | 3378 | Hong Kong | — | 127 |
| IMGT Corporation Limited | 456570 | South Korea | — | 127 |
| Targanta Therapeutics Corp. Delisted | — | United States of America | — | 127 |
| ENCHIRA BIOTECHNOLOGY CORP Delisted | — | United States of America | — | 126 |
| PhaseRx Inc Delisted | PZRX | United States of America | — | 126 |
| G2GBIO, Inc. | 456160 | South Korea | — | 125 |
| VACCINOGEN INC Delisted | — | United States of America | — | 125 |
| Claritas Pharmaceuticals, Inc. Delisted | CLAZF | Canada | — | 122 |
| Beijing Biostar Pharmaceuticals Co., Ltd. | 2563 | Hong Kong | — | 121 |
| Ambrilia Biopharma Inc. Delisted | AMB | Canada | — | 120 |
| Heartseed Inc. | 219A | Japan | — | 120 |
| DIACRIN INC Delisted | — | United States of America | — | 119 |
| Nanjing Leads Biolabs Co., Ltd. | 9887 | Hong Kong | — | 119 |
| PSYCHECEUTICAL BIOSCIENCE, INC. Delisted | — | United States of America | — | 118 |
| SYDYS CORP Delisted | — | United States of America | — | 118 |
| AQUILA BIOPHARMACEUTICALS INC Delisted | — | United States of America | — | 117 |
| HighTide Therapeutics, Inc. | 2511 | Hong Kong | — | 117 |
| PRISM BioLab Co.,LTD | 206A | Japan | — | 117 |
| PROTEINA CO.,LTD. | 468530 | South Korea | — | 117 |
| MEDISTEM INC. Delisted | — | United States of America | — | 116 |
| Omthera Pharmaceuticals Inc Delisted | OMTH | United States of America | — | 116 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.